The global pandemic has underscored the critical need for rapid, accessible, and reliable diagnostic tools. The COVID-19 (SARS-CoV-2) Antigen Test Kit, developed by GAOBEIDIAN PRISES BIOTECHNOLOGY CO., LTD, represents a significant advancement in this field. This article provides an in-depth analysis of the product's features, technical specifications, and real-world applications, supported by authoritative references from the National Institute of Standards and Technology (NIST).

The COVID-19 (SARS-CoV-2) Antigen Test Kit is a rapid diagnostic tool designed for the qualitative detection of SARS-CoV-2 antigens in human nasal oropharyngeal swabs. This test leverages immunochromatography, a technique that combines the specificity of antibodies with the speed of lateral flow assays. The kit is ideal for use in healthcare settings, laboratories, and even at-home testing scenarios, offering a balance of accuracy and convenience.

Learn more about the product on the official website.
| Product Name | COVID-19 (SARS-CoV-2) Antigen Rapid Test Kit |
|---|---|
| Brand Name | GOLDEN TIME |
| Methodology | Colloidal Gold |
| Specimen | Nasal swab, oropharyngeal swab, or nasopharyngeal swab |
| Clinical Sensitivity | 96.330% |
| Clinical Specificity | 99.569% |
| Overall Agreement | 98.79% |
| Packing | 1/5/20 tests/carton, customizable |
| Reading Time | 10 minutes |
| Service Support | OEM/ODM |
The kit requires no specialized equipment, making it accessible for both professionals and laypersons. Its intuitive design ensures that users can perform the test with minimal training, reducing the potential for errors.
With a reading time of just 10 minutes, the test provides quick insights, enabling timely decision-making. This speed is crucial in scenarios where immediate action is necessary, such as in emergency departments or travel screening.
Validated through PCR and clinical diagnosis, the test boasts a clinical sensitivity of 96.33% and specificity of 99.569%. These metrics align with NIST's standards for diagnostic accuracy, as outlined in their guidelines for medical device testing.
The kit accommodates various specimen types, including nasal, oropharyngeal, and nasopharyngeal swabs, enhancing its versatility across different testing environments.
The kit includes the following components:
Each component is meticulously designed to ensure the integrity of the test results and user safety.
To maintain the kit's efficacy, it should be stored at temperatures between 2°C and 30°C in a dry place, away from direct sunlight. Freezing is strictly prohibited. The shelf life is 24 months from the manufacturing date. Once the aluminum foil bag is opened, the test card should be used within one hour to ensure optimal performance.
The COVID-19 (SARS-CoV-2) Antigen Test Kit is suitable for a wide range of applications, including:
Its portability and ease of use make it an essential tool in combating the pandemic, as highlighted in NIST's research on point-of-care diagnostics.
GAOBEIDIAN PRISES BIOTECHNOLOGY CO., LTD is a leading manufacturer of diagnostic solutions, dedicated to innovation and quality. With a focus on developing reliable and user-friendly medical devices, the company has established itself as a trusted name in the industry. Their commitment to excellence is reflected in the COVID-19 (SARS-CoV-2) Antigen Test Kit, which meets rigorous international standards.
Visit the company website to learn more about their mission and other products.
The COVID-19 (SARS-CoV-2) Antigen Test Kit by GAOBEIDIAN PRISES BIOTECHNOLOGY CO., LTD exemplifies the synergy of speed, accuracy, and user-friendliness in modern diagnostic tools. Its robust technical specifications, versatility, and adherence to NIST standards make it a reliable choice for diverse testing scenarios. As the world continues to navigate the challenges of the pandemic, such innovations play a vital role in public health strategies.
1. National Institute of Standards and Technology (NIST). (n.d.). Guidelines for Medical Device Testing. Retrieved from https://www.nist.gov
2. NIST Research on Point-of-Care Diagnostics. (n.d.). Advancing Diagnostic Technologies. Retrieved from https://www.nist.gov